E Fund Management Co., Ltd. Sangamo Therapeutics, Inc Transaction History

E Fund Management Co., Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$1.66 - $3.67 $3,326 - $7,354	-2,004 Reduced 5.42%	35,003 $62,000
Q4 2022 Feb 14, 2023	BUY	$2.77 - $5.07 $25,716 - $47,069	9,284 Added 33.49%	37,007 $116,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $16,520 - $24,722	-3,869 Reduced 12.25%	27,723 $136,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $27,850 - $52,729	8,491 Added 36.76%	31,592 $131,000
Q1 2022 May 12, 2022	BUY	$5.23 - $7.82 $59,533 - $89,015	11,383 Added 97.14%	23,101 $134,000

Q4 2021 Feb 11, 2022	BUY	$7.29 - $10.97 $4,898 - $7,371	672 Added 6.08%	11,718 $88,000
Q3 2021 Nov 12, 2021	SELL	$9.01 - $12.01 $8,730 - $11,637	-969 Reduced 8.06%	11,046 $100,000
Q1 2021 May 12, 2021	BUY	$10.88 - $17.05 $130,723 - $204,855	12,015 New	12,015 $150,000

138

100M

35.5K

65.8K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $56.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.